Palantir faces mounting parliamentary pressure over NHS data security concerns

Palantir Technologies has faced increasing scrutiny from MPs across multiple parties over data security concerns relating to its work with the NHS, as the American-based analytics firm justifies its £300m agreement with NHS England. The dispute intensified after instructions issued to every NHS trust in England directing them to use Palantir’s “core products” in hospitals starting this month, as reported by the British Medical Journal. Labour MP Emily Darlington has cautioned that involving a overseas technology firm with medical information represents a major security risk, whilst the Liberal Democrats have declared the firm should be kept away from our national security infrastructure. The Green Party and Conservative MPs have also demanded heightened scrutiny of the company’s information protection capabilities, as Palantir’s UK leadership maintains the software presents no risk to patient information.

The debate centred on a US technology company’s NHS involvement

The backlash against Palantir’s partnership with the NHS focuses on worries regarding entrusting a overseas tech firm with private healthcare records. Critics maintain that relying on a US-based organisation for such vital NHS infrastructure poses inherent security risks, particularly given the company’s prior associations to defence and intelligence activities. The timing of this dispute is noteworthy, as NHS trusts have been directed to roll out Palantir’s platforms this month, creating uncertainty about whether appropriate safeguards and parliamentary review were in place before such large-scale rollout started across the healthcare system.

Palantir’s UK management has acted quickly to address these concerns, with executives stressing that the company has no business incentive to access or use patient data. The firm insists that its Foundry platform operates similarly to commonly-deployed applications like Microsoft Office, which processes NHS information without the software provider accessing it. Nevertheless, the breadth of political opposition—spanning Labour, Liberal Democrat, Green, and Conservative MPs—indicates that reassurances from company officials alone may fall short to quell parliamentary concerns about data sovereignty and security protocols.

• Labour MP Emily Darlington raised concerns about “significant security threat” from international tech involvement
• Liberal Democrats declared organisation “should be kept well away from our critical security systems”
• Green Party leader characterised Palantir “a defence surveillance firm”
• Conservative MP Wendy Morton called for review of data security measures

What Palantir provides and why the NHS needs it

Palantir’s Foundry platform addresses a persistent issue that has plagued the NHS for decades: the inability of distinct healthcare systems to interact seamlessly with one another. Across the health service, disconnected data systems exist in silos—a patient’s GP records cannot smoothly integrate with their hospital files, and clinic systems function separately from A&E departments. This separation creates inefficiencies, impedes timely care, and depletes essential capacity. The £300 million contract granted to Palantir at the end of 2023 is intended to solve this vital technical issue by establishing a single integrated platform.

The company’s software allows NHS trusts to access, combine and evaluate previously disconnected databases without necessitating high-cost overhauls or replacements. By linking these separate infrastructures, Palantir asserts its platform delivers tangible benefits: it delivers live oversight of patient queues, tracks hospital supplies and equipment, pinpoints free spaces and surgical suites, and significantly enhances clinical coordination. These capabilities resolve actual operational pain points that medical staff and managers encounter regularly. The technology embodies a realistic effort to modernise NHS infrastructure without abandoning established expenditure in older platforms.

How the federated information system works

Rather than forcing the NHS to consolidate or replace its existing IT systems, Palantir’s federated data platform operates as a connective layer between independent systems. It enables data stored in different databases—whether at general practice surgeries, hospitals or clinics—to be accessed and analysed together without moving or centralising the data itself. This “distributed” approach means each organization retains control of its own information whilst allowing queries across systems and analysis. The platform essentially acts as a sophisticated translator, enabling incompatible systems to share insights without requiring wholesale technological replacement.

Palantir executives have repeatedly made comparisons to standard workplace applications to explain the technology’s operation. Just as Microsoft Excel or Word handles NHS data without Microsoft accessing it, Palantir’s software integrates information without the company itself accessing patient records. The data stays under NHS control and ownership throughout the process. This architectural design is at the heart of the company’s response to security allegations, though critics challenge whether such guarantees are sufficient given the confidential nature of healthcare information and Palantir’s prior involvement with military and intelligence agencies.

Political resistance spans the breadth

The backlash against Palantir’s NHS involvement has proven notably bipartisan, with politicians across the political spectrum voicing serious reservations. Labour MP Emily Darlington warned the BBC that entrusting a foreign technology company with confidential patient data represents “a significant security threat”, whilst Conservative MP Wendy Morton has called for increased oversight of the firm’s data protection capabilities. The Liberal Democrats have taken an stronger stance, arguing that Palantir “should be nowhere near our critical security systems”, whilst Green Party leader Zack Polanski has highlighted the company’s troubled past, labelling it “a military surveillance company”. This unusual political consensus suggests authentic worry extends beyond partisan positioning.

Palantir’s defence and the government’s stance

Palantir has launched a strong response against the mounting criticism, with UK executive vice-chair Louis Mosley appearing on the BBC’s Politics Live to address concerns directly. Mosley welcomed parliamentary scrutiny, voicing confidence that the company was “delivering for” patients through its Foundry data-sharing platform. He emphasised that Palantir has no financial incentive to obtain patient data, comparing the arrangement to standard software like Microsoft Excel or email deployed across the NHS. As Mosley explained, the company operates under strict regulatory parameters that prohibit data access, making patient information protection a non-issue rather than a vulnerability.

The government has largely backed Palantir’s involvement, with Labour MP Alex McIntyre, sitting on the Commons Health and Social Care select committee, defending the contract whilst emphasising strict safeguards. McIntyre stressed that the government has set “red lines” guaranteeing data remains in the UK and under NHS ownership, with Palantir strictly banned from accessing or disclosing patient records. This position reflects the administration’s view that the contract’s gains from merging fragmented NHS systems outweigh security concerns, as long as robust governance frameworks continue to exist. The government’s stance suggests confidence in the contractual arrangements, though this continues to be challenged by opposition parties.

The organisation’s key arguments

• Palantir has no commercial interest in obtaining or profiting from UK patient data whatsoever.
• Software integrates incompatible NHS databases with no company gaining access to records.
• Arrangement reflects how Microsoft tools operate within NHS with no concerns about data access.

What comes next for NHS data consolidation

The £300m Palantir deal with NHS England, granted at the close of 2023, is scheduled for renewal at the start of next year, presenting a critical juncture for the government’s data integration strategy. Before that renewal process, Parliament will probably increase its oversight of the arrangement, with select committees potentially conducting formal inquiries into security safeguards and accountability structures. The increasing parliamentary pressure suggests any contract renewal will encounter significant opposition unless the government can demonstrate strong protections and clear governance frameworks. The coming months will be pivotal in ascertaining whether Palantir maintains its central role in NHS digital infrastructure or whether alternative solutions gain traction.

Meanwhile, NHS trusts have been required to introduce Palantir’s main platforms in hospital settings beginning this month, as per guidance issued by NHS England. This deployment continues notwithstanding the political backlash, suggesting the government remains committed to the integration project. However, the parallel parliamentary scrutiny could compel the Department of Health to undertake further independent security reviews or set up new supervisory bodies before the contract renewal. The conclusion will probably determine not only the NHS’s digital future but also create precedent for how the UK government conducts partnerships between the health service and international technology providers.